Mortality estimates of central nervous system TB in India.

Int J Tuberc Lung Dis

Central TB Division, Ministry of Health and Family Welfare, Government of India, New Delhi, India.

Published: November 2023

Download full-text PDF

Source
http://dx.doi.org/10.5588/ijtld.23.0308DOI Listing

Publication Analysis

Top Keywords

mortality estimates
4
estimates central
4
central nervous
4
nervous system
4
system india
4
mortality
1
central
1
nervous
1
system
1
india
1

Similar Publications

Multilevel modelling of the determinants of under-five deaths in South Africa: Evidence from the 2016 Demographic Health Survey.

Afr J Reprod Health

November 2024

SAMRC/Wits Developmental Pathways for Health Research Unit, Department of Paediatrics, Faculty of Health Sciences, School of Clinical Medicine, University of the Witwatersrand, Johannesburg, South Africa.

Although South Africa is among the countries with lower under-five mortality rates in sub-Saharan Africa, the country has failed to meet the national targets set to achieve the Millennium Development Goals. The study aimed to examine multilevel determinants of deaths of children under five in South Africa. Secondary data from the 2016 South Africa Demographic Health Survey was used to conduct bivariate and multilevel logistic regression analyses.

View Article and Find Full Text PDF

Real-world data on treatment outcomes or the quality of large-scale chronic hepatitis B (CHB) treatment programs in sub-Saharan Africa (SSA) is extremely difficult to obtain. In this study, we aimed to provide data on the prevalence and incidence of mortality, loss to follow-up (LFTU), and their associated factors in patients with CHB in three treatment centres in Eritrea. Additional information includes baseline clinical profiles of CHB patients initiated on nucleos(t)ide analogue (NUCs) along with a comparison of treatment with Tenofovir disoproxil fumarate (TDF) vs.

View Article and Find Full Text PDF

Economic burden of Type 2 diabetes in Iran in 2022.

BMC Public Health

January 2025

Department of Health Management, Policy & Economics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.

Background: Diabetes mellitus, particularly Type 2 diabetes (T2D), represents a significant global health challenge, with its prevalence steadily rising over the past few decades. This study was conducted with the aim of estimating the economic burden of T2D in Iran.

Methods: This study employed a prevalence-based approach to estimate the economic burden of T2D and its attributable complications in adults above 20 years old in Iran for 2022.

View Article and Find Full Text PDF

Background: There is uncertainty about the use of the CHA2DS2-VASc score to predict clinical events in patients with Takotsubo syndrome (TTS). This study aimed to assess the short-term prognostic role of CHA2DS2-VASc score in this population.

Methods: All admissions with a primary diagnosis of TTS were included using data from the National Inpatient Sample database during 2016-2019.

View Article and Find Full Text PDF

The Burden of Multiple Myeloma in China: Trends from 1990 to 2021 and Forecasts for 2050.

Cancer Lett

January 2025

Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University, Beijing 100044, China; Collaborative Innovation Center of Hematology, Soochow University, Suzhou 215006, China. Electronic address:

This study updates the disease burden of multiple myeloma (MM) in thirty-three provincial administrative units in China from 1990 to 2021 and forecast the disease burden for 2050. Data from the 2021 Global Burden of Disease (GBD) database was used for analysis. In 2021, there were an estimated 17,250 new MM cases and 12,984 deaths in China.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!